Thus, while expression of PD-L1 expression in KRAS/TP53 double-mutated tumours could contribute to a better prognosis in the univariate analysis, multivariate and subgroup analyses highlight its role as an independent prognostic marker. The gene discussed is TP53; the disease is neoplasm.